Maximum Dose and Adverse Effects of Ashwagandha KSM-66
Based on the available research evidence, the maximum safe dose of KSM-66 Ashwagandha root extract is 1200 mg per day (600 mg twice daily), with excellent safety demonstrated at doses up to 1000 mg daily for extended periods.
Maximum Recommended Dosage
The research literature consistently demonstrates safety across the following dosing ranges:
- Standard therapeutic dose: 300-600 mg twice daily (600-1200 mg/day total) 1, 2, 3
- Well-tolerated dose: 1000 mg/day for up to 4 weeks 4
- Long-term safety validated: Up to 12 months of continuous use 5
- Preclinical NOAEL: 2000 mg/kg body weight/day in rats (90-day toxicity study) 6
The most commonly studied and recommended dose is 600 mg per day (300 mg twice daily), which has been extensively validated for both efficacy and safety 1, 2, 3.
Adverse Effects Profile
Documented Adverse Events
The safety profile of KSM-66 is remarkably favorable across multiple clinical trials:
Mild adverse events (18 total events in 191 patients over 12 months):
- All were mild in severity
- Resolved spontaneously without intervention
- No serious adverse events reported 5
Gastrointestinal effects: Mild nausea, though significantly less common than with other herbal preparations 7
No clinically significant changes observed in:
- Hepatic function (ALT, AST remained stable) 5
- Renal function 1, 4, 5
- Thyroid function (TSH, T3, T4) 1, 4
- Hematological parameters 1
- Vital signs (blood pressure, heart rate, temperature) 1
Potential Concerns from Literature Review
While clinical trials show excellent safety, theoretical concerns exist 7:
Hepatotoxicity: Rare case reports exist, but controlled trials show no hepatic dysfunction at standard doses 5
Thyroid effects: Theoretical thyrotoxicosis risk, though clinical trials demonstrate no thyroid parameter changes 1, 4
Immune hypersensitivity: Theoretical concern, but not observed in clinical trials
Drug interactions: Potential CYP450 enzyme interactions theoretically possible 7
Beneficial Effects at Therapeutic Doses
At the recommended 600 mg/day dose, significant improvements were documented in:
- Cortisol reduction: Significant decrease in serum cortisol (p < 0.001) 5
- Testosterone increase: Both free and total testosterone significantly increased (p < 0.05) 5
- Cognitive function: Improved episodic memory, working memory, and attention accuracy 2
- Cardiorespiratory endurance: Enhanced VO2 max 8
- Quality of life: Significant improvements in SF-12 scores 5
- Stress and anxiety: Reduced PSS and HAM-A scores 3
Clinical Recommendations
Starting dose: 300 mg twice daily (600 mg/day total)
Maximum dose: 600 mg twice daily (1200 mg/day total) for short-term use
Long-term maintenance: 300-500 mg twice daily (600-1000 mg/day)
Duration: Safe for continuous use up to 12 months based on available evidence 5
Important Caveats
- Pregnancy: Avoid use due to insufficient safety data
- Hepatic disease: Monitor liver function, though clinical trials show no hepatotoxicity
- Thyroid disorders: Monitor thyroid function despite no changes observed in trials
- Concurrent medications: Consider potential CYP450 interactions, particularly with immunosuppressants or thyroid medications
The evidence strongly supports that KSM-66 Ashwagandha at doses up to 1200 mg/day is safe and well-tolerated, with the optimal therapeutic dose being 600 mg/day (300 mg twice daily) for most clinical applications 1, 2, 3, 5.